Your browser doesn't support javascript.
loading
Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin.
Poór, Miklós; Boda, Gabriella; Mohos, Violetta; Kuzma, Mónika; Bálint, Mónika; Hetényi, Csaba; Bencsik, Tímea.
Affiliation
  • Poór M; Department of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, Pécs H-7624, Hungary; János Szentágothai Research Center, University of Pécs, Ifjúság útja 20, H-7624 Pécs, Hungary. Electronic address: poor.miklos@pte.hu.
  • Boda G; Department of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, Pécs H-7624, Hungary.
  • Mohos V; Department of Pharmacology, University of Pécs, Faculty of Pharmacy, Szigeti út 12, Pécs H-7624, Hungary.
  • Kuzma M; Department of Forensic Medicine, Medical School, University of Pécs, Szigeti út 12, Pécs H-7624, Hungary.
  • Bálint M; Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, Pécs H-7624, Hungary.
  • Hetényi C; Department of Pharmacology and Pharmacotherapy, University of Pécs, Medical School, Szigeti út 12, Pécs H-7624, Hungary.
  • Bencsik T; Department of Pharmacognosy, University of Pécs, Faculty of Pharmacy, Rókus utca 2, Pécs H-7624, Hungary.
Biomed Pharmacother ; 102: 912-921, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29710546

Full text: 1 Database: MEDLINE Main subject: Silymarin / Flavonoids / Serum Albumin / Cytochrome P-450 CYP2C9 Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Silymarin / Flavonoids / Serum Albumin / Cytochrome P-450 CYP2C9 Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Year: 2018 Type: Article